HSP90B2P and atrial fibrillation: Hereto, we recommend a large – ideally randomized controlled – trial using continuous rhythm monitoring to determine the AF burden together with a validated patient-observed-effect questionnaire, in order to gain insight into the (patient-specific) effects of L-glutamine on HSP levels and AF burden.